Search PubMed⌕ Search

PubMed · 3930134

Gastrointestinal dysfunction in the critically ill: nutritional implications.

Abstract

Parenteral therapy is frequently indicated for initial repletion in the severely malnourished patient. Attention should be paid to the nutrients required for initial repletion based on the patient's metabolic needs at the time of therapy, as well as allowance for adequate calories for repletion of body and muscle mass. After the initiation of parenteral therapy and the adequate replacement of fluids and electrolytes, slow introduction of oral or enteric feeding is reasonable. This probably is best handled initially by the use of a nasogastric or nasoenteric feeding tube. However, if the patient willingly ingests oral feedings, the oral route is certainly favorable. Close attention should be paid to the adequacy of gastric emptying. Symptoms of abdominal bloating and diarrhea may require modification of the rate at which oral intake is progressing.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J A Wilson. 1985. Gastrointestinal dysfunction in the critically ill: nutritional implications.. https://pubmed.ncbi.nlm.nih.gov/3930134/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.

Ulcerative colitis (UC) is characterized by impairment of the epithelial barrier and the formation of ulcer-type lesions, which result in local leaks and generalized alterations of mucosal tight junctions. Ultimately, this results in increased basal permeability. Although disruption of the epithelial barrier in the gut is a hallmark of inflammatory bowel disease and intestinal infections, it remains unclear whether barrier breakdown is an initiating event of UC or rather a consequence of an underlying inflammation, evidenced by increased production of proinflammatory cytokines. UC is less common in smokers, suggesting that the nicotine in cigarettes may ameliorate disease severity. The mechanism behind this therapeutic effect is still not fully understood, and indeed it remains unclear if nicotine is the true protective agent in cigarettes. Nicotine is metabolized in the body into a variety of metabolites and can also be degraded to form various breakdown products. It is possible these metabolites or degradation products may be the true protective or curative agents. A greater understanding of the pharmacodynamics and kinetics of nicotine in relation to the immune system and enhanced knowledge of gut permeability defects in UC are required to establish the exact protective nature of nicotine and its metabolites in UC. This review suggests possible hypotheses for the protective mechanism of nicotine in UC, highlighting the relationship between gut permeability and inflammation, and indicates where in the pathogenesis of the disease nicotine may mediate its effect.

Colitis, Ulcerative↗